NDA 18467, held by Sun Pharm Inds Inc. Technetium Tc-99m Disofenin Kit.
As of Nov 13, 2026, NDA 18467 (Hepatolite), held by Sun Pharm Inds Inc, was first approved by FDA on Mar 16, 1982, with 17 approved supplements and 0 published complete response letters.
| Dec 29, 1993 | Supplement 14Efficacy (new indication or use) | Approved | |
| May 19, 1989 | Supplement 9Efficacy (new indication or use) | Approved | None posted |
| Mar 16, 1982 | Original applicationNew molecular entity · Priority review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| HepatoliteN/A · injectable;injection | Technetium Tc-99m Disofenin Kit | Discontinued |
| Oct 30, 2015 | Supplement 31Manufacturing · Priority review | Approved | None posted |
| Apr 25, 2013 | Supplement 25Manufacturing · Priority review | Approved | None posted |
| May 16, 2002 | Supplement 18Manufacturing · Priority review | Approved | None posted |
| Mar 15, 2000 | Supplement 17Manufacturing · Priority review | Approved | None posted |
| Feb 7, 2000 | Supplement 16Manufacturing · Priority review | Approved | None posted |
| Nov 5, 1997 | Supplement 15Manufacturing · Priority review | Approved | None posted |
| Dec 29, 1993 | Supplement 14Efficacy (new indication or use) | Approved | |
| Dec 29, 1993 | Supplement 13Labeling | Approved | |
| May 19, 1989 | Supplement 11Manufacturing · Priority review | Approved | None posted |
| May 19, 1989 | Supplement 10Labeling | Approved | None posted |
| May 19, 1989 | Supplement 9Efficacy (new indication or use) | Approved | None posted |
| May 19, 1989 | Supplement 7Manufacturing · Priority review | Approved | None posted |
| May 2, 1989 | Supplement 12Manufacturing · Priority review | Approved | None posted |
| Feb 28, 1986 | Supplement 5Manufacturing · Priority review | Approved | None posted |
| Jun 7, 1983 | Supplement 2Labeling | Approved | None posted |
| Apr 26, 1983 | Supplement 1Manufacturing · Priority review | Approved | None posted |
| Apr 21, 1983 | Supplement 3Manufacturing · Priority review | Approved | None posted |
| Mar 16, 1982 | Original applicationNew molecular entity · Priority review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters